Solvay's Stock Jumps 4.29% at Midday
Solvay's stock shows a 4.29% increase at midday this Wednesday, trading at 26.26 euros after closing the previous day at 25.18 euros. This surge comes amid a generalized rebound of European indices, with the CAC 40 up 1.38% during the session. The Belgian chemical company is recovering after a significant downtrend over the past year.
Solvay Stock Benefits from a Strong Upward Movement
This Wednesday, Solvay's stock is benefiting from a clear upward movement, bringing its price above the 20-day moving average (26.15 euros), which it had lost in recent sessions. However, the stock remains below its 50-day moving average at 26.44 euros, which poses an immediate technical barrier. The RSI, at 43, indicates the stock is still in a zone of relative weakness, suggesting there is room for growth before reaching overbought levels.
This rebound is part of the positive momentum observed in European markets since the announcement on March 23 by Donald Trump of a de-escalation between Washington and Tehran around the Strait of Hormuz. Although the situation remains fragile, the postponement of American strikes and the resumption of dialogue have helped the CAC 40 recover after a very volatile session at the beginning of the week. The SBF 120 is also up 1.38% in the session. However, Solvay's recent performance remains fragile: the stock has declined by 1.57% over seven days and 21.61% over the year, indicating a deep-seated bearish trend that has not yet reversed.
Busy Financial Calendar Ahead for Solvay
Solvay's financial calendar looks busy in the coming weeks. The publication of the first quarter 2026 results is scheduled for May 7, followed by the annual general meeting on May 12. These events will provide insights into the operational trajectory of the group after a year marked by a significant decline in share price.
From a technical standpoint, the major resistance is at 28.50 euros, approximately 8.5% above the current price. The identified support at 24.50 euros held during the recent downturn, providing a reference floor for traders. The nearly zero beta (-0.06) of the stock indicates a low correlation with major indices, a characteristic sometimes sought in times of uncertainty. Monthly volatility remains contained at 8.17%, contrasting with the tensions observed on the VIX, which was at 26.78 in its last available measurement. However, the approach of the quarterly publication could revive fluctuations in the stock in the coming weeks.
